Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Pfizer
(NY:
PFE
)
28.71
-0.17 (-0.59%)
Official Closing Price
Updated: 4:10 PM EDT, Aug 15, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Pfizer
< Previous
1
2
...
7
8
9
10
11
12
13
14
15
...
99
100
Next >
3 Discounted Stocks Poised for a Major Upswing
June 02, 2024
Explore discounted upswing stocks with strong financials and strategic advantages heading for a rebound soon.
Via
InvestorPlace
Blue-Chip Blunders: 7 Stocks to Sell as Management Missteps Mount
June 02, 2024
Sometimes top companies make bottom-shelf decisions; such is the case with these seven blue-chip stocks to sell.
Via
InvestorPlace
3 Stocks to Buy for Huge Income
June 01, 2024
All 3 of these stocks have a yield above 5%.
Via
The Motley Fool
Takeda and Pfizer Announce Four-Year Results from Positive Phase 3 HD21 Trial of Additional ADCETRIS® (brentuximab vedotin) Combination in Frontline Hodgkin Lymphoma
June 01, 2024
From
Takeda Pharmaceutical Company Limited
Via
Business Wire
Pfizer's Options Frenzy: What You Need to Know
May 30, 2024
Via
Benzinga
Pfizer’s ADCETRIS® Regimen Produces Clinically Meaningful Improvement in Overall Survival in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
June 01, 2024
From
Pfizer Inc.
Via
Business Wire
Is Pfizer the Best Dividend Stock for You?
June 01, 2024
Short-term expectation worries have elevated Pfizer's dividend yield.
Via
The Motley Fool
Pfizer Highlights 'Unprecedented' 5 Year Data From Cancer Drug In Rare Form Of Advanced Lung Cancer
May 31, 2024
Pfizer's Phase 3 CROWN trial results show Lorbrena significantly outperforms Xalkori in treating ALK-positive advanced NSCLC.
Via
Benzinga
Moderna Wins FDA Approval For Second-Ever Product; Why Its RSV Vaccine Could Dominate Pfizer, GSK
May 31, 2024
Moderna's RSV vaccine will launch a year behind Pfizer and GSK, but it could become the market leader over the next five years.
Via
Investor's Business Daily
Exposures
Product Safety
How To Earn $500 A Month From Pfizer Stock
May 31, 2024
New York-based Pfizer currently has a dividend yield of 5.96% — a quarterly dividend of 42 cents a share ($1.68 a year).
Via
Benzinga
Pfizer’s LORBRENA® CROWN Study Shows Majority of Patients with ALK-Positive Advanced Lung Cancer Living Beyond Five Years Without Disease Progression
May 31, 2024
From
Pfizer Inc.
Via
Business Wire
Ginkgo Bioworks Stock: Bull vs. Bear
May 31, 2024
This innovative biotechnology company hopes to turn things around.
Via
The Motley Fool
Is Pfizer an Excellent Dividend Stock to Buy for Passive Income Investors?
May 31, 2024
Pfizer's dividend yield is rising as the stock price is falling.
Via
The Motley Fool
Dyadic International Inc. (DYAI): Bird Flu Vaccine Development Amid Rising Pandemic Concerns
May 30, 2024
Via
AB Newswire
Exposures
COVID-19
Moderna Pops After Confirming The U.S. Government Could Back Its Bird Flu Vaccine
May 30, 2024
The company expects to have data soon from its Phase 1 and Phase 2 study of a bird flu vaccine.
Via
Investor's Business Daily
Beat the Dow Jones With This Cash-Gushing Dividend Stock
May 30, 2024
With one decade of doubling the Dow Jones' total return under its belt, Zoetis looks ready to deliver another 10 years of outperformance.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
Steady Gains, Solid Yields: 7 Low-Beta Stocks Paying 5%+ Dividends
May 30, 2024
These are the low-beta dividend stocks to buy, as they represent companies with strong fundamentals and robust cash flow visibility.
Via
InvestorPlace
3 Dividend Stocks to Double Up on Right Now
May 30, 2024
The stories for these great dividend stocks are better than many might think.
Via
The Motley Fool
Are Boomers Crashing The Economy Or Saving It? Why Investors Are Perplexed And What You Can Do To Prepare
May 29, 2024
Mass retirement of boomers could have major economic impact. Experts anticipate both risks and opportunities from the largest wealth transfer in history.
Via
Benzinga
Topics
Economy
Retirement
Exposures
Economy
Pension
AstraZeneca Just Massively One-Upped Pfizer. Here's What It Means for the Stock
May 29, 2024
Both businesses have road maps for the future, but one is better.
Via
The Motley Fool
7 Must-Own Stocks to Hold for the Second Half of 2024
May 29, 2024
Explore 7 must-own stocks for the second half of the year set to drive substantial yields across multiple innovative sectors.
Via
InvestorPlace
If You Can Only Buy One Biotech Stock in May, It Better Be One of These 3 Names
May 29, 2024
Between FDA approvals and product pipelines, it takes diligence to keep up with which biotech stocks to buy.
Via
InvestorPlace
Exposures
Product Safety
If You Can Only Buy One Value Stock in May, It Better Be One of These 3 Names
May 29, 2024
Although the ideas may be less appreciated, these value stocks to buy can deliver surprisingly positive results for contrarians.
Via
InvestorPlace
Sarepta Downgraded As FDA Decision Date Approaches, Shares Up 50% Over Last Six Months
May 28, 2024
RBC Capital Markets downgrades Sarepta Therapeutics following increased FDA label expansion expectations for Elevidys and recent stock surge.
Via
Benzinga
Exposures
Product Safety
Revenge of the Apes: 3 Reddit WallStreetBets Stocks That Could Pop Next
May 28, 2024
The retail trading army could cause potential breakouts in these three WallStreetBets stocks that are being discussed more and more.
Via
InvestorPlace
Jim Cramer: Celestica Makes A 'Comeback,' Sell This Movie Theater Stock,
May 28, 2024
Jim Cramer called Celestica Inc. "terrific" after the Toronto-based company reported better-than-expected first-quarter financial results.
Via
Benzinga
Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 4% Dividend Yields
May 28, 2024
Via
Benzinga
2 Beaten-Down Dividend Stocks Near 52-Week Lows. Should You Buy the Dips?
May 28, 2024
The major market indexes keep hitting new highs, but these stocks haven't participated in the bull run.
Via
The Motley Fool
Dividend Deals: 3 Overlooked Stocks Offering Incredible Value
May 27, 2024
Build a portfolio that steadily generates passive income for you. Here are three overlooked dividend stocks to consider.
Via
InvestorPlace
Got $500? 3 Pharma Stocks to Buy and Hold Forever
May 26, 2024
These players might even beat the market when the conditions are right.
Via
The Motley Fool
< Previous
1
2
...
7
8
9
10
11
12
13
14
15
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.